SEARCH RESULTS FOR: "Tag: SGMO"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2019(4)
2018(4)
2017(5)
2015(1)
CATEGORIES
Analyst Update(3)
Analyst Upgrades(1)
Buzz Stocks(1)
Intraday Option Activity(1)
Quantitative Analysis(2)
Stocks On the Move(7)
Technical Analysis(1)

7/8/2019 9:53 AM
Two biotech names are making a run up the Nasdaq charts this morning. First there's Sangamo Therapeutics Inc (NASDAQ:SGMO), up 10% to trade at $12.53, after the gene therapy specialist reported positi...
4/2/2019 12:43 PM
The shares of Sangamo Therapeutics Inc (NASDAQ:SGMO) are on fire, after the California-based biotech reported positive data in a phase 1/2 study for its gene therapy hemophilia treatment that's being...
3/12/2019 12:23 PM
Biotech company Sangamo Therapeutics Inc (NASDAQ:SGMO) just named Jason Fontenot, Ph.D. as its Senior Vice President, Cell Therapy. Fontenot will be in charge of the genomic medicine concern's develo...
2/7/2019 2:58 PM
Stocks are staring at stiff losses following fresh U.S.-China trade news. Among individual names making big moves lower are ePort parent USA Technologies, Inc. (NASDAQ:USAT), biotech Sangamo Therap...
9/5/2018 2:53 PM
It's a mixed trading day on Wall Street, with the tech sector lagging on regulatory concerns. Among individual stocks making volatile moves are genome editing firm Sangamo Therapeutics Inc (NASDAQ:S...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center